TTRX

Turn Therapeutics Inc. Common Stock (TTRX)

Stock · NASDAQ · Health Care

$9.84as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$3.28
Industry
Biotechnology: Pharmaceutical Preparations

Turn Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • TTRX
    Turn Therapeutics Inc. Common Stock
    $9.84
    ▼ 2.67%
    Market cap $263.33MP/E
  • ELDN
    Eledon Pharmaceuticals Inc. Common Stock
    $3.19
    ▼ 3.92%
    Market cap $264.75MP/E
    $1.35$4.6
  • ALXO
    ALX Oncology Holdings Inc. Common Stock
    $2
    ▼ 2.44%
    Market cap $259.71MP/E
    $0.96$2.66
  • VRXA
    Veraxa Biotech AG Ordinary Shares
    $1.36
    ▼ 5.56%
    Market cap $258.78MP/E
    $1.32$27.36
  • IMRX
    Immuneering Corporation Class A Common Stock
    $4.99
    ▼ 4.22%
    Market cap $269.79MP/E
    $3.86$10.08
  • BCYC
    Bicycle Therapeutics plc American Depositary Shares
    $4.21
    ▼ 2.77%
    Market cap $270.87MP/E
    $3.75$9.16
  • FULC
    Fulcrum Therapeutics Inc. Common Stock
    $3.85
    ▲ 0.00%
    Market cap $283.06MP/E
    $2.83$15.74

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
449.8K
Total value held
$1.44M
Institutional holders
19
Top holders this quarter
  • Unknown70.5K
  • Unknown69.8K
  • Unknown65.7K
  • Unknown49.5K
  • Unknown30.0K
  • Unknown23.7K
  • Unknown19.7K
  • Unknown19.7K
  • Unknown18.0K
  • Unknown17.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.